Professor Hamdy has been a Consultant Urological Surgeon for the past 26 years. He is currently the Nuffield Professor of Surgery & Urology at the University of Oxford, Head of the Nuffield Department of Surgical Sciences, Divisional Director for Surgery, Women’s and Oncology at the Oxford University Hospitals, and Fellow of Balliol College.
He specialises and has vast experience in the treatment of prostate and bladder cancer. He qualified from the University of Alexandria, Egypt, trained in Surgery and Urology in the UK at Liverpool, Sheffield and Newcastle. He Introduced a multi-specialty robotic surgical programme to Oxford in 2009, and pioneered robot-assisted surgery at Oxford. He was first to perform robot-assisted laparoscopic radical prostatectomy and has undertaken several hundred procedures since 2009 with excellent audited outcomes.
He was elected Fellow of the Academy of Medical Sciences in 2007, NIHR Senior Investigator in 2010, and appointed by NHS England as Vice-Chair of the Clinical Expert Group on prostate cancer in 2017.
PA email : firstname.lastname@example.org
Treatments and tests offered by Professor Freddie Charles Hamdy at Nuffield Health
- Prostate screening
- Prostate surgery
- Radical prostatectomy
- Prostate resection (TURP)
Professor Hamdy leads one of four Oxford National Institute for Health Research (NIHR) Biomedical Research Centre Clusters of five themes: Surgical Innovation and Evaluation, Imaging, Clinical Analytics, Digital Health, and Musculoskeletal Sciences. He was elected Fellow of the Academy of Medical Sciences in 2007 and NIHR Senior Investigator in 2010, and was commended by the national UK Research Excellence Framework (REF) in 2014 for the strength and quality of surgical research conducted by his Department. He was appointed by NHS England as Vice-Chair of the Clinical Expert Group on prostate cancer in 2017.
His research activities encompass clinical, translational and basic science programmes on the biology of urological malignancies.
He is Chief Investigator of the Health Technology Assessment NIHR ProtecT study on prostate cancer, the largest of its kind worldwide, the PART trial testing partial ablation of the prostate, and the Cancer Research UK ProMOTE study of molecularly targeted image-guided surgery in prostate cancer.
- Fellow, Royal College of Surgeons of Edinburgh (FRCSEd)
- Fellow, Royal College of Surgeons of England (FRCSEng)
- Fellow, Academy of Medical Sciences Member, American Association of GU Surgeons (FMedSci)
- Member, German Urological Society
- Member, European Association of Urology
Other posts held
- Consultant Urological Surgeon: Oxford University Hospitals NHS Foundation Trust
- Nuffield Professor of Surgery & Urology: University of Oxford
- Vice-chair: NHS England Clinical Expert Group in prostate cancer
Insurers Professor Freddie Charles Hamdy works with
Professor Freddie Charles Hamdy works with the following private medical insurance providers:
- Aviva Health
- AXA Health
Professor Freddie Charles Hamdy does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Professor Freddie Charles Hamdy does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Professor Freddie Charles Hamdy does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.